Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study to Assess the Safety and Efficacy of Infliximab for the Treatment of Hidradenitis Suppurativa

NCT00795574 is registered in ClinicalTrials.gov with Florida Academic Dermatology Centers as lead sponsor.

NCT NCT00795574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00795574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study to Assess the Safety and Efficacy of Infliximab for the Treatment of Hidradenitis Suppurativa
Lead sponsor
Florida Academic Dermatology Centers
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2005
Completion date
August 31, 2008
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hidradenitis suppurativa